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SEROEPIDEMIOLOGY OF TOXOPLASMOSIS IN WOMEN OF CHILDBEARING AGE FROM A 
MARGINAL COMMUNITY OF MARACAIBO, VENEZUELA
Odelis Diaz-Suárez & Jesus eStevez
SuMMarY
The aim of this study was to determine the prevalence of anti-T. gondii total and IgM antibodies in women of childbearing age. 
One hundred serum samples of women were studied with age range from 11 to 45 years old. Samples were chosen by random. The 
determination of total antibodies was carried out through the indirect hemagglutination technique and IgM antibodies by ELISA’s 
technique. The statistical analysis was carried out through the Chi square and the Spearman correlation tests. The theoretical estimated 
incidence of congenital toxoplasmosis was calculated, according to the annual increment of antibody prevalence among the age groups. 
The overall prevalence of toxoplasmosis was 33%, while only six individuals (18.2%) were positive to IgM. The highest prevalence 
was observed in the 11-35 year-old age group. The theoretical estimated incidence was 1.5 for 100 pregnancies in women of 21-25 
year-old group; it decreased until 0.1% in the 41-45 year-old age group. The findings show a high prevalence of toxoplasmosis in this 
community with a high infection risk in women of the studied age group and the high cat population observed, suggesting that the 
transmission way by contaminated soils may play a main role in the spreading of toxoplasmosis in this community.
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iNtrODuCtiON
Toxoplasmosis is the most common parasitic infection in the world. 
The clinical infection is often asymptomatic in healthy people, but it 
can cause severe complications in immunosuppressed subjects4,9. The 
infection of pregnants frequently is an asymptomatic or mild disease, 
difficulting diagnosis and can produce deleterious effects in the fetus. 
The early detection of this infection is the high importance to prevent 
those effects27,30. In spite of, in several developing countries, the early 
detection and prevention programs have been implemented, only it is 
known the incidence of toxoplasmosis vertical transmission throughout 
the frequency of tetarogenic effects in the population of newbirths27. 
T. gondii infection is widely spread in Latin America, mainly in 
tropical areas, where shows prevalence range of 65% in the population15,28. 
High prevalence has been reported in Chile10,28, Brazil5,19, Ecuador17, 
Panamá15,31, Costa Rica18, Mexico34, Cuba24 and Venezuela8,12,16,23,25,29. 
In reproductive age women have been observed prevalence between 
four to 93% in some countries1,7,11,14,25,27.
Some studies have determined the toxoplasmosis prevalence in 
several urban groups and communities from Venezuela as follow: 31.8-
61% in pregnants16,23, 41.8-53.5% in individuals between 0 to 60 years 
old8,29, 57.6% and 66.7% in children under 15 years old8,33, and 36.6% 
in subject between eight months to 76 years old in marginal areas12. In 
rural areas, 39%29 in 18 to 20 years old soldiers, and 49.3% individuals 
between 0 to 60 years old23. 
The information about T. gondii infection and geographical 
distribution in Venezuela is fractioned, since most studies have been based 
on non-representative hospital samples of the population. 
The aim of this study was to determine the seroprevalence of T. 
gondii antibodies in childbearing age women of a suburban marginal 
community from Maracaibo, State Zulia, Venezuela, who constitute a 
high risk group for congenital toxoplasmosis because the community has 
a high cat population together with a high annual newbirths rate. 
PatieNt aND MetHODS
Studied area and population: Puerto Caballo is a coastal marginal 
community, located at the north of Estado Zulia, Venezuela. It has two 
(waist management and electricity) of the basic services. The economical 
level of the population is very low. 
Most of houses of this town are distributed lineally, one beside the 
other and in front of the main sandy street, they do not present dividing 
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fences and are built with walls of bricks, thin roofs and, cement or sand 
floors. The number of individuals living in each house varies from five 
to 16.
The cat population is high, they stroll freely around the community, 
visiting numerous houses and depositing their excrements around the 
houses and inside them. 
The community shows a poor sanitary condition, lacking of an 
appropriate effectual excretes system. The potable water is often obtained 
through cistern trucks and it is stored in uncover containers.
Most of their inhabitants live off fishing. Their consumption of meats 
is scarce, and the meat they eat is not well cooked.
The total population of Puerto Caballo, at the moment of this study, 
was formed by 1145 individuals of both sexes with an age range between 
three months to 70 years old. The sample belonged to 100 women in 
childbearing age (12 to 49 years old), who were chosen by random.
The women consent or their representatives were obtained, before 
to their inclusion in the study. A survey to obtain basic information such 
as: age, occupation, number and time between pregnancies, sanitary and 
socioeconomic conditions, condition of habitat and nutrition habits. This 
investigation was approved by the Ethical Committee of Zulia University 
and, it was designed following the parameters of the Declaration of 
Helsinki.
Methods: The blood samples were obtained by veined punction and 
centrifuged 2500 r.p.m by five min. The recollected sera were frozen at 
-20 ºC until their analyses. The total antibodies were determined by the 
indirect hemagglutination technique (Toxotest HAI Wiener Lab), and 
the IgM antibodies through the ELISA’s technique (ETI-TOXOK-M. 
DiaSorin S.R.L). A reactive dilution above 1:64 was considered as 
positive to HAI.
Statistical analysis: Data were expressed in distribution of 
frequencies. It was carried out by Chi-square test and the Fischer exact 
analysis, as it corresponded, to determine significant differences among 
the studied groups. It was performed Spearman correlation analysis 
to define relationship among the studied variables. It is taken 95% as 
confidence index. It was considered significant all probability lesser 
than 0.05 (p < 0.05).
The accumulated prevalence, increased seropositivity percentage, 
annual increment of the seropositive percentage, increment of percentage 
for nine months and, theoretical incidence estimated of congenital 
toxoplasmosis were calculated based on the mathematical methods used 
by PUNDA-POLIC et al.27 for data with heterogeneous age groups. To 
estimate congenital toxoplasmosis incidence was used the estimated 
Latin-American incidence mean (10%) of toxoplasmosis calculated of 
several studies5,8,10,12,16,17,18,23,24,29,33,34.
reSuLtS
Table 1 represents the prevalence of anti- T. gondii total antibodies and 
the theoretical annual estimated incidence of congenital toxoplasmosis in 
childbearing age women from the studied groups. The overall prevalence 
was 33.0%, being observed picks of prevalence in the age groups of 
11-15 (45%), 21-25 (53.8%) and 31-35 years old (60.0). The highest 
annual increases were 9.1% and 4.8% in 11-15 and 21-25 year-old 
groups, respectively. The highest risk of theoretical estimate congenital 
toxoplasmosis was 2.7 for 100 pregnancies in 11-15 year-old group. The 
theoretical incidence of congenital toxoplasmosis decreased gradually of 
2.7% for the 11-15 years old group to 0.1% for the groups of 40 years old. 
The overall theoretical estimate incidence of congenital toxoplasmosis 
was 0.8 for 100 pregnancies.
Distribution of anti-T. gondii total and IgM antibodies is shown in Table 
2. The overall positive percentage was 33.0% (33/100) for total antibodies 
and 18.2% (6/33) for IgM antibodies. The highest positive percentages of 
total antibodies were observed in 31-35 years old women (60.0%), while 
to IgM antibodies the highest incidence was determined in 41-45 years old 
women. The geometric mean of total antibody titers (TGM) was 302.8, 
being higher in the 11-15 year-old age group. The prevalence of 31-35 
years old group shows a statistical difference regarding 16-20 (p < 0.05) 
and 36-40 (p < 0.01) year-old groups. Furthermore, the 21-25 and 36-40 
years old groups were different (p < 0.05).
table 1
Prevalence of anti-T. gondii total antibodies and estimation of theorical annual incidence of congenital toxoplasmosis by age group in women of childbearing age















11-15 5/11 45.5 45.5 45.5 9.1 6.8 2.7
16-20 3/17 17.6 55.1 9.6 1.9 1.4 0.6
21-25 7/13 53.8 79.3 24.2 4.8 3.6 1.5
26-30 6/22 27.3 84.9 5.7 1.1 0.8 0.3
31-35 6/10 60.0 94.0 9.0 1.8 1.4 0.5
36-40 1/14 7.1 94.4 0.4 0.1 0.1 0.0
41-45 5/13 38.5 96.6 2.2 0.3 0.3 0.1
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The distribution of total antibody titers can be observed in Table 3. 
The highest percentage was (72.2%, 24/33) of low titers (1:64 - 1:512), 
while the lowest percentage was (27.8%, 9/33) of high titers (1:1024 - 
1:4096). 
DiSCuSSiON
Obtained results indicate that the T. gondii infection is endemic in 
the studied population. Several studies suggest that the primary infection 
occurs in early stages of life and it is strongly influenced by close contact 
with oocyst in feces of infected cats which contaminate soils. The overall 
prevalence of antibodies was lower than the ones reported in previous 
studies in urban8,29, and rural populations29, and similar to the ones 
observed in other marginal communities from Estado Zulia12 .
The seroprevalence was lower than the ones reported in other 
countries such as: Senegal (40.3%)11, Turkey (39.6%)14, Bangladesh 
(38.5%)1, Croatia (38.1%)27 and, Yugoslavia (57-93%)7, higher than 
the one observed in India (7.72%)25, and similar to the one reported in 
Mexico (33.4%)34.
The high percentage (66.7%) of non-infected women observed in 
childbearing age demonstrated that they are in a high risk condition 
to acquire this infection during the pregnancy, whose consequences in 
the fetus are known2,3,27. Early studies suggest a progressive increase of 
prevalence observed in  women in the first decades of life, it may indicate 
that they are often infected when reach the childbearing age27,30. The 
transmission of T. gondii infection is only possible to the fetus when 
women are infected during the pregnancy; the risk of fetal infection 
should be low in the rest of female population. On the contrary, the present 
findings determined that 54.5% of the younger women of childbearing 
age are negative to anti-Toxoplasma antibody test, showing estimated 
risk index of 2.7 to 100 pregnancies. 
The highest prevalence (total antibodies) and incidence (IgM) 
demonstrated in the 11-15, 21-25, and 31-35 years-old groups and the 
statistical differences observed between these groups and the 16-20 and 
36-40 years old groups, suggests intermittent periods of Toxoplasma 
infection, with average periods of five years where the no-infected 
population seems to have a higher susceptibility to the parasite. Since the 
pregnancy has been considered an immunosuppressant condition25,35, this 
stage may allow a high infection risk for some pathologies. The fact that 
these susceptible periods match to the media time between pregnancies 
(4.43 ± 2.15 years) in the studied women may give explanation to the 
observed results. The finding of highest titers in the age groups with the 
highest prevalence seems to corroborate this fact, a close and lasting 
contact with T. gondii antigen join to periods of high susceptibility may 
explain it25. Further studies are required to clear these results. 
In spite of the aforesaid picks of prevalence, the high titer geometric 
mean (TGM) of 11-15 years old group and an inverse relationship 
between the age and TGM suggest that the women of the studied 
community were infected in the first decades of life, which is in agreement 
with previous studies1,11,13,25. The TGM of 16-35 years old group is 
very near to overall TGM (302.8), what could correspond to persistent 
circulation of Toxoplasma antigen in the population. It is probable due to 
the high cat population, which contaminate the soils inside and outside 
of housing, because people are in close contact with the oocysts for long 
time. The accumulated risk of suffering toxoplasmosis during pregnancy 
table 2
Distribution of total and IgM antibodies against T. gondii by age group




Positives/Examined % Positives/Examined %
11-15 5/11 45.5 0/5 0.0 2352.5
16-20 3/17 17.6 0/3 0.0 256.0
21-25 7/13b 53.8 1/7 14.3 231.9
26-30 6/22 27.3 0/6 0.0 228.1
31-35 6/10a 60.0 2/6 33.3 287.4
36-40 1/14 7.1 0/1 0.0 64.0
41-45 5/13 38.5 3/5 60.2 128.0
Total 33/100 33.3 6/33 18.2 302.8
a
 Statistical difference regarding 16-20 (p < 0.05) and 36-40 (p < 0.01) age groups; bStatistical difference regarding 36-40 (p < 0.05) age group.
table 3
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determined in the studied women, increases the possibility that their 
fetus may present congenital toxoplasmosis. Some studies reported 
highest risk in the products of women above 30 years old, while the 
lowest incidence would be seen in newborns of women under 36 years 
old25. The estimated risk of acquired toxoplasmosis to pregnant and 
fetus determined in the present study points out a similar epidemiologic 
behavior. The percentage of high titers (27.2%) may suggest early or 
active disease, or a high reinfection rate. Development of more sensitive 
and discriminative techniques are needed to clear the immunologic status 
of individuals infected with T. gondii. At the present time, IgM antibody is 
not considered as a reliable marker of early infection, since several studies 
have demonstrated persistence of IgM antibodies for long time22,32. 
Among several transmission ways described for T. gondii, infection 
by contaminated soils, eat raw meat, or transplacental4,9, the first one 
seems to play a main role in the spreading of infection into the studied 
community. The high percentage of intestinal parasites (84.6%), mainly 
geohelminths, determined by a previous study in this community 
(unpublished data), it is a strong evidence of prolonged and close contact 
with contaminated soils, since helminths and T. gondii oocysts follow 
the same oral-fecal infection route. The ingestion of raw meat do not 
seem to play any role in the toxoplasmosis transmission, once diet of the 
studied community contains few well-cooked meat.
The social-economic status of studied women is very low and the 
prevalence of T. gondii infection is high, and seems to support the inverse 
relationship between economic condition and toxoplasmosis reported 
by other studies1,34.
The domestic and wild cats have been considered the main source 
of Toxoplasma oocysts, although the main risk factor is the relation 
between the cat population and the size of their areas to defecate. The 
populations of rural cats are often higher than the urban cat ones, but the 
urban cats defecate in limited areas: sandbanks inside the housing, small 
gardens and surrounding of houses. In these areas, the concentration of 
Toxoplasma oocysts may be very high, therefore the infection risk also 
could be increased in humans, while rural cats have wide areas to defecate 
and the oocyst concentration of these areas is lower than in the previous 
case, being the infection of low risk in the rural human population.
The use of uncovered recipients to store water may lead to the 
spreading of the infection by water contamination with cat feces. 
Indeed, the water has been implied as a way of epidemic and endemic 
transmission in places where it is stored in open containers6,15. Therefore, 
the infection risk may be increased when the population lack potable 
water and this is stored in inadequate containers.
The world incidence of T. gondii primary infection acquired 
during pregnancy varies widely with a range between 1/100 to 1/3000 
pregnancies20,26,27. In Venezuela, previous studies are not available 
about the toxoplasmosis incidence; this study estimated the theoretical 
incidence of congenital toxoplasmosis by the increment of anti-T. gondii 
antibodies in the studied population. According to the obtained results, 
it is known that the frequency of primary infection into the age groups 
may provide an adequate estimation of the number of pregnancies under 
risk in this population. These results point out to the adolescent and 
young adult women as the most vulnerable groups for the acquisition of 
primary toxoplasmosis during the pregnancy. This fact has been reported 
previously20. It would be enlightened to compare the toxoplasmosis 
incidence forecast with data based on the conversion of IgG levels, 
frequency and persistence of anti-T.gondii IgM antibodies and, the 
IgG avidity test21. The last test, although routine in Europe and U.S.A. 
is uncommon in Latin America, and discriminates between early and 
chronic Toxoplasma infection.
The findings obtained in the present study emphasize the need to 
establish preventive programs against T. gondii infection, since only 
prospective studies can provide real data about the maternal incidence 
even the frequency of congenital toxoplasmosis. Although toxoplasmosis 
can be an avoidable disease it justifies the call for implementation of 
such programs. 
reSuMO
Soroepidemiologia da toxoplasmose em mulheres em idade fértil 
em comunidade marginal de Maracaibo, venezuela
A finalidade do presente estudo foi determinar a prevalência de 
anticorpos totais e IgM anti-Toxoplasma gondii, em mulheres em idade 
fértil. Estudaram-se 100 amostras de soro de mulheres com idade entre 
11 e 45 anos. Amostras foram escolhidas ao acaso. A determinação de 
anticorpos totais foi realizada com a técnica de hemaglutinação indireta 
e a determinação de anticorpos IgM, pela técnica de ELISA. A análise 
estatística foi realizada usando a prova do Chi quadrado e a correlação de 
Spearman. A incidência teórica estimada da toxoplasmose congênita foi 
calculada de acordo com o incremento anual da prevalência de anticorpos 
entre os diversos grupos de acordo com a idade. A prevalência geral de 
toxoplasmose foi de 33%, enquanto somente seis pacientes (l8,2%) foram 
positivos para IgM. A prevalência maior foi observada no grupo de 11-35 
anos de idade. A incidência teórica estimada foi de 1,5 por 100 mulheres 
grávidas no grupo de 21-25 anos de idade; diminuiu até 0,1% no grupo 
de 41-45 anos de idade. Os resultados obtidos refletem alta prevalência 
de toxoplasmose nesta comunidade, além de alto risco de infecção nas 
mulheres no grupo de idade estudado, sugerindo-se que a transmissão 
através de fezes de gato, pode ter papel preponderante. 
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